H. Honová

Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.

L. Petruzelka, M. Zemanova, A. Pazdro, 2010, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Efficacy of weekly trastuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes

F. Janku, L. Petruzelka, B. Konopasek, 2002 .

[Circulating tumor cells and prostate cancer prognosis].

T. Zima, K. Kološtová, V. Soukup, 2014, Casopis lekaru ceskych.

Gene Expression Analysis of Immunomagnetically Enriched Circulating Tumor Cell Fraction in Castration-Resistant Prostate Cancer

T. Zima, K. Kološtová, V. Soukup, 2018, Molecular Diagnosis & Therapy.

Prognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest® System for Detection of Circulating Tumor Cells.

T. Zima, K. Kološtová, V. Soukup, 2016, Anticancer research.

Report on the first patient group of the phase I BNCT trial at the LVR-15 reactor

V. Dbalý, F. Tovaryš, V. Mareš, 2004 .

Gene Expression Analysis of Immunomagnetically Enriched Circulating Tumor Cell Fraction in Castration-Resistant Prostate Cancer

T. Zima, K. Kološtová, V. Soukup, 2018, Molecular Diagnosis & Therapy.

C163 Prostate-specific antigen level and detection of circulating tumour cells in castration-resistant prostate cancer

T. Zima, K. Kološtová, V. Soukup, 2013 .